Company Encyclopedia
View More
name
Aesthetic Medicine
CP20072.HK
News
View More

Perfect Medical Health Management Limited Issues Profit Warning for 2025

Perfect Medical Health Management Limited has issued a profit warning for the six months ending September 30, 2025. The profit attributable to shareholders is expected to be between HK$93 million and HK$98 million, down from HK$141 million in the same period in 2024. However, this is a significant increase of at least 40% compared to the second half of the financial year 2025. The company is still finalizing its interim results.

Tip Ranks·
HK
01830
-1.47%
Tip Ranks·
HK
01830
-1.47%

Fosun Pharma Unit's Registration Application for Langerhans Cell Histiocytosis Drug Accepted in China

Fosun Pharma Unit's Registration Application for Langerhans Cell Histiocytosis Drug Accepted in China

marketscreener·
HK
02196
-3.86%
SH
600196
-1.72%
marketscreener·
HK
02196
-3.86%
SH
600196
-1.72%

BUZZ-3SBio drops most in seven months on unit spin-off plans

3SBio Inc's shares dropped 8.9% to HK$29.52, marking the largest decline since April, due to plans to spin off its 87.16%-owned unit, Mandi Inc, for a separate listing on the Hong Kong stock exchange. The Stock Exchange confirmed the spin-off, with 3SBio not retaining any interest in Mandi post-listing. Despite the drop, 3SBio's stock is up 400% YTD, while the Hang Seng Biotech Index rose 77%.

Reuters·
HK
01530
-9.44%
Reuters·
HK
01530
-9.44%

3SBio spin-off Mandi banks on hair-loss and weight-loss drugs in Hong Kong IPO bid

Mandi, a consumer healthcare arm of 3SBio backed by Alibaba Health, filed for an IPO in Hong Kong, focusing on its minoxidil hair-loss products. The IPO aims to leverage Hong Kong's booming market, with plans to use the capital for product expansion and R&D. 3SBio will exit its stake in Mandi, which will raise funds through a global offering. Mandi's net profit rose 14.5% to 390.3 million yuan in 2024, and it is developing new drugs in phase III trials.

南华早报·
HK
01530
-9.44%
HK
00241
-4.46%
南华早报·
HK
01530
-9.44%
HK
00241
-4.46%

3SBio Proposes Spinoff, Hong Kong Listing of Unit Mandi

3SBio Proposes Spinoff, Hong Kong Listing of Unit Mandi

marketscreener·
HK
01530
-9.44%
marketscreener·
HK
01530
-9.44%
Posts
View More

$Nova Lifestyle(NVFY.US)💎 NVFY (Nova Lifestyle) — Order Book Snapshot 💎

📈 Latest Price: $5.42

📊 Buy Orders: 300.8K shares

📊 Sell Orders: 30.7K shares

🔥 Buy-side pressure dominates with a 10:1 ratio ...

  • 0